BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
月曜日, 9 28

Abeona Therapeutics Inc

ABEONASDAQ
Trade with Public
Trade with Public
$5.40
-0.03-0.55%
近くで: Sep 24, 5:00 PM EST
$5.40
-0.03-0.55%
プレマーケット: 4:04 AM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Abeona Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Abeona Therapeutics (ABEO).

Price Target Range — 10 Quarters

Analyst Consensus — 5 Analysts

5Buy
Consensus RatingBuy# Analysts5Avg. Consensus PT$20Upside to Avg. PT+268.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →
DateFirmAnalystActionRating ChangePrice Target
Sep 18, 2026Cantor FitzgeraldKristen KluskaPT RaiseOverweight$28→$30
Sep 17, 2026Roth CapitalBoobalan PachaiyappanInitiateBuy$17
More with Benzinga EdgeGet Access

Analyst Ratings News

Apple To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Friday

Analysts downgraded XENE, NFLX and MGA, while raising price targets for OCS, INSW, ABEO and STNG.
Avi Kapoor

PRO
Cantor Fitzgerald Maintains Overweight on Abeona Therapeutics, Raises Price Target to $30

Cantor Fitzgerald analyst Kristen Kluska maintains Abeona Therapeutics (NASDAQ:ABEO) with a Overweight and raises the price target from $28 to $30.
Benzinga Newsdesk

PRO
Roth Capital Initiates Coverage On Abeona Therapeutics with Buy Rating, Announces Price Target of $17

Roth Capital analyst Boobalan Pachaiyappan initiates coverage on Abeona Therapeutics (NASDAQ:ABEO) with a Buy rating and announces Price Target of $17.
Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Abeona Therapeutics, Lowers Price Target to $21

Oppenheimer analyst Jeff Jones maintains Abeona Therapeutics (NASDAQ:ABEO) with a Outperform and lowers the price target from $22 to $21.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:ABEO) with a Buy and maintains $20 price target.
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

市場データ提供元 Benzinga API

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved